Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)

Shanghai Fosun Pharmaceutical (Group) Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	53,709	61,592	86,922	113,862	125,791	65,086
Market Cap Growth	-29.51%	-29.14%	-23.66%	-9.48%	93.27%	12.70%
Enterprise Value	84,160	89,228	110,109	134,998	147,717	86,903
Last Close Price	22.51	24.74	34.35	47.08	51.64	25.26
PE Ratio	33.10	27.80	24.02	25.52	36.13	19.49
PS Ratio	1.49	1.49	1.98	2.92	4.15	2.28
PB Ratio	1.28	1.09	1.61	2.35	2.74	1.66
P/FCF Ratio	-55.01	-32.04	-52.01	-110.01	-67.73	-88.00
P/OCF Ratio	15.30	18.04	20.61	28.91	48.76	20.20
EV/Sales Ratio	2.08	2.16	2.51	3.46	4.87	3.04
EV/EBITDA Ratio	22.29	23.25	19.87	32.27	36.18	23.64
EV/EBIT Ratio	59.38	75.34	32.19	53.22	56.42	36.52
EV/FCF Ratio	-86.20	-46.41	-65.88	-130.43	-79.53	-117.49
Debt / Equity Ratio	0.59	0.62	0.56	0.53	0.52	0.56
Debt / EBITDA Ratio	9.18	8.54	5.25	5.86	5.63	5.74
Debt / FCF Ratio	-35.50	-18.22	-18.06	-24.59	-12.89	-29.62
Asset Turnover	0.36	0.38	0.44	0.44	0.38	0.39
Inventory Turnover	2.79	3.01	3.76	3.82	3.03	3.20
Quick Ratio	0.69	0.73	0.78	0.75	0.71	0.89
Current Ratio	0.93	1.00	1.06	1.04	1.01	1.17
Return on Equity (ROE)	4.20%	5.23%	7.70%	10.55%	9.25%	10.28%
Return on Assets (ROA)	0.78%	0.67%	2.13%	1.79%	2.05%	2.03%
Return on Capital (ROIC)	0.97%	0.84%	2.70%	2.21%	2.50%	2.52%
Earnings Yield	3.02%	3.87%	4.29%	4.15%	2.91%	5.10%
FCF Yield	-1.63%	-3.12%	-1.92%	-0.91%	-1.48%	-1.14%
Dividend Yield	1.20%	1.09%	1.22%	1.19%	0.83%	1.54%
Payout Ratio	136.05%	102.89%	63.64%	40.48%	50.09%	56.13%
Buyback Yield / Dilution	-0.40%	-2.40%	-1.74%	-	-	-1.57%
Total Shareholder Return	0.80%	-1.31%	-0.51%	1.19%	0.83%	-0.03%

Source: S&P Capital IQ. Standard template. Financial Sources.